Dr Nathan Papa

Role: Research Methodologist

Selected publications

See all publications

2025
The Journal of Urology10.1097/JU.0000000000004734
The Blind Spot of PSMA-PET Staging? Intraductal Carcinoma of the Prostate Is Overrepresented in Patients With No Uptake Pattern on Prostate-Specific Membrane Antigen Positron Emission Tomography and High-Grade Prostate Cancer.
David C Chen, Zein Alhamdani, Nathan Papa, Edward Shen, Natalia Kovaleva, Maggie Gao, Louise Emmett, Michael S Hofman, Andrew Ryan, Andrew M Scott, Sze Ting Lee, Nathan Lawrentschuk, Marlon L Perera, Damien M Bolton
2025
The Lancet. Oncology10.1016/S1470-2045(25)00339-0
Prognostic and predictive value of baseline PSMA-PET total tumour volume and SUVmean in metastatic castration-resistant prostate cancer in ENZA-p (ANZUP1901): a substudy from a multicentre, open-label, randomised, phase 2 trial.
Louise Emmett, Nathan Papa, Shalini Subramaniam, Megan Crumbaker, Andrew Nguyen, Anthony M Joshua, Shahneen Sandhu, Andrew Weickhardt, Sze-Ting Lee, Siobhan Ng, Roslyn J Francis, Jeffrey C Goh, David A Pattison, Thean Hsiang Tan, Ian D Kirkwood, Narjess Ayati, Claire Niu, Michael S Hofman, Andrew James Martin, Hayley Thomas, Ian D Davis, Martin R Stockler,
2025
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine10.2967/jnumed.124.268896
Diagnostic Potential of Ga-NeoB PET/CT with Estrogen Receptor- and Progesterone Receptor-Positive Breast Cancer Undergoing Staging or Restaging for Metastatic Disease.
Zahra Sabahi, Andrew Nguyen, Keith Wong, Sherrington Li, Nathan Papa, Elgene Lim, Rachel F Dear, Alexander M Menzies, Frances Boyle, Yoland Antill, Belinda E Kiely, Benjamin C Forster, Cindy Mak, Diana Adams, Lina Pugliano, Andrew Spillane, Shikha Sharma, Adam Hickey, Aron Poole, Shikha Agrawal, Sobia Khan, Narjess Ayati, Louise Emmett
2025
BJU International10.1111/bju.16608
Impact of intraprostatic PSMA maximum standardised uptake value following prostatectomy: a systematic review and meta-analysis.
David C Chen, Siyu Huang, Nathan Papa, Shankar Siva, Damien M Bolton, Nathan Lawrentschuk, Louise Emmett, Declan G Murphy, Michael S Hofman, Marlon L Perera
2024
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine10.2967/jnumed.124.267606
Comparison of Posttherapy 4- and 24-Hour [Lu]Lu-PSMA SPECT/CT and Pretherapy PSMA PET/CT in Assessment of Disease in Men with Metastatic Castration-Resistant Prostate Cancer.
Mina Swiha, Sarennya Pathmanandavel, Nathan Papa, Zahra Sabahi, Sherrington Li, Alex Zheng, Sobia Khan, Maria Ayers, Shikha Sharma, Megan Crumbaker, Andrew Nguyen, Lyn Chan, Narjess Ayati, Louise Emmett

See all Garvan publications

Explore our research

Our impact

Our people

News and resources

About us

Support Us

Dr Nathan Papa

Selected publications

The Blind Spot of PSMA-PET Staging? Intraductal Carcinoma of the Prostate Is Overrepresented in Patients With No Uptake Pattern on Prostate-Specific Membrane Antigen Positron Emission Tomography and High-Grade Prostate Cancer.

Prognostic and predictive value of baseline PSMA-PET total tumour volume and SUVmean in metastatic castration-resistant prostate cancer in ENZA-p (ANZUP1901): a substudy from a multicentre, open-label, randomised, phase 2 trial.

Diagnostic Potential of Ga-NeoB PET/CT with Estrogen Receptor- and Progesterone Receptor-Positive Breast Cancer Undergoing Staging or Restaging for Metastatic Disease.

Impact of intraprostatic PSMA maximum standardised uptake value following prostatectomy: a systematic review and meta-analysis.

Comparison of Posttherapy 4- and 24-Hour [Lu]Lu-PSMA SPECT/CT and Pretherapy PSMA PET/CT in Assessment of Disease in Men with Metastatic Castration-Resistant Prostate Cancer.